Does Sjogren's syndrome affect only the lacrimal gland in the eye? Time to replace the missing stones
| dc.contributor.author | Gürlevik, Uğur | |
| dc.contributor.author | Karakoyun, Ahmet | |
| dc.contributor.author | Yaşar, Erdoğan | |
| dc.date.accessioned | 2021-05-03T09:32:33Z | |
| dc.date.available | 2021-05-03T09:32:33Z | |
| dc.date.issued | 2021 | |
| dc.department | Tıp Fakültesi | |
| dc.description.abstract | Purpose: This study aimed to reveal the cause of meibomian gland disease and meibomian gland loss in patients with Sjogren's syndrome (SS) as the leading factor for dry eyes. Methods: The study included a total of 30 patients with SS and dry eye symptoms and a control group of 50 age- and gender-matched healthy subjects. The dryness parameters of all the participants were evaluated. At first, meibography was performed to measure meibomian gland loss using noninvasive methods. Later, meibomian gland expression and secretion quality were evaluated using silt-lamp biomicroscopy. Correlations between the measurements were analyzed statistically. Results: In patients with SS, MG loss was significantly greater than in the control group (19.7 +/- 71%, 12.7 +/- 9.6%, P < 0.001). All dry eye parameters (tear film breakup time, Schirmer's test score, OSDI, stain score, dry eye disease) were statistically significant in the SS group. There was an extremely negative correlation between upper MB loss and BUT (P = 0.08, r: -0.781). There was an extremely positive correlation between upper MB loss and staining (P = 0.015, r: 0.739). An extremely negative correlation was determined between sub-MB loss and BUT (P = 0.18, r:-0.781), and a moderately positive significant correlation was found between sub-MB loss and staining (P = 0.031, r: 0.659). Conclusion: The results of this study demonstrated that patients with SS were at a higher risk of being exposed to meibomian gland loss, which directly leads to the severe dry eye symptoms associated with SS. | |
| dc.identifier.doi | 10.4103/ijo.IJO_2383_19 | |
| dc.identifier.endpage | 57 | en_US |
| dc.identifier.issue | 1 | en_US |
| dc.identifier.pmid | 33323573 | |
| dc.identifier.scopusquality | Q2 | |
| dc.identifier.startpage | 53 | en_US |
| dc.identifier.uri | https:/dx.doi.org/10.4103/ijo.IJO_2383_19 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12451/7923 | |
| dc.identifier.volume | 69 | en_US |
| dc.identifier.wos | WOS:000601311400014 | |
| dc.identifier.wosquality | Q3 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.publisher | Wolters Kluwer Medknow Publications | |
| dc.relation.ispartof | Indian Journal of Ophthalmology | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | Dry Eye Disease | |
| dc.subject | Meibography | |
| dc.subject | MGD | |
| dc.subject | TBUT | |
| dc.subject | Sjogren's Syndrome | |
| dc.title | Does Sjogren's syndrome affect only the lacrimal gland in the eye? Time to replace the missing stones | |
| dc.type | Article |
